Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome
Author(s) -
Leon Jonker,
Chantal A Lebbink,
Marjolijn C.J. Jongmans,
Rutger A. J. Nievelstein,
Johannes H. M. Merks,
E.J.M. Nieveen van Dijkum,
Thera P. Links,
Nicoline Hoogerbrugge,
A.S. Paul van Trotsenburg,
Hanneke M. van Santen
Publication year - 2020
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000508872
Subject(s) - medicine , cowden syndrome , thyroid carcinoma , pten , thyroid cancer , thyroid , incidence (geometry) , oncology , pediatrics , cohort , genetics , apoptosis , physics , pi3k/akt/mtor pathway , optics , biology
PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in the PTEN gene. Children with a germline PTEN mutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guidelines have focused on thyroid surveillance in these children, but studies substantiating these recommendations are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom